Lonza News
Most Popular Lonza Story
Lonza board boots CEO Borgas
Pressure from Asian low-cost chemical and drug ingredient suppliers, combined with high Swiss energy costs impacting manufacturing operations, have yielded poor financial performance at Lonza and the Read more...
Latest Headlines
- January 26, 2012
- December 7, 2011
- October 3, 2011
- June 22, 2011
- April 11, 2011
- September 8, 2010
- June 9, 2010
- February 9, 2010
- February 1, 2010
- November 10, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
